Leukocyte and platelet markers of blood in the dynamics of the hospital period in patients with acute myocardial infarction: the ability to predict the development of long-term adverse events

Main Article Content

O. M. Parkhomenko
V. O. Shumakov
T. V. Talayeva
I. V. Tretyak
O. V. Dovhan

Abstract

The aim – to create a new method of assessing the development of long-term complications in STEMI patients by studying blood cell composition and its adaptation to practical application in general clinical practice.
Materials and methods. The study was involved 148 patients with acute myocardial infarction (AMI) who was admitted from January 2014 to June 2020 to the intensive care unit. Some patients were evaluated retrospectively and were in group 1 (n=92). Group 2 – 56 patients, who were studied prospectively. The groups of patients did not differ in clinical and anamnestic characteristics and treatment. The study provided an annual observation period. The endpoint in group 1 was: death, stroke, exacerbation of coronary heart disease – including the need for revascularization, the developement or decompensation for heart failure, which led to hospitalization (in addition, group 2 was analyzed for onset of cardiac death).
Results and discussion. There complex indicators were built, based on the analysis of the clinical profile and dynamics of laboratory parameters in patients with the onset of the endpoint – a modified leukocyte index (mLI), which contains the values ​​of the number and percentage of granulocytes, lymphocytes and monocytes on days 1, 3 and 10 of STEMI and leukocyte-platelet index (mLPI), which additionally includes indicators of platelet inhomogeneity in size (PDWc and P-LCR). These indices with their limit values ​​(mLI > 140 units and mLPI > 242 units) were more informative in predicting distant cardiovascular events than other laboratory markers (including neutrophil-leukocyte ratio, NLR). In a prospective study branch (group 2), the mLI and mLPI indicators also turned out to be more informative than other markers (in particular, the NLR indicator) in determining the propensity to occur as a combined endpoint (area under the curve 0.71 for both; p<0.0001), so and death (areas under the curve 0.78 and 0.84, respectively; p<0.0001). Based on the data obtained, a computer algorithm has been created that simplifies the risk assessment in AMI patients using the developed indicators.
Conclusions. Created leukocyte and leukocyte-platelet indices are highly informative in predicting the risk of complications in patients within a year after AMI.

Article Details

Keywords:

acute myocardial infarction, general blood test, prognosis, leukocyte-platelet index.

References

Пархоменко О.М., Амосова К.М., Дзяк Г.В. та ін. Реко­­­мендації Асоціації кардіологів України щодо ведення пацієнтів з гострим коронарним синдромом з елевацією сегмента ST // Укр. кардіол. журн.– 2013.– Додаток 3.

Пархоменко О.М., Шумаков О.В., Талаєва Т.В. та ін. Нові можливості оцінювання ризику розвитку госпітальних ускладнень у хворих з гострим інфарктом міокарда з елевацією сегмента ST за даними вивчення клітинного складу крові // Укр. кардіол. журн.– 2021.– № 1 (28).– C. 7–18.

All WHO fact sheets: Cardiovascular diseases (CVDs), 11 jun 2021.

Ayka B., Akın F., Celik O. et al. Neutrophil to lymphocyte ratio is related to stent thrombosis and high mortality in patients with acute myocardial infarction // Angiology.– 2015.– Vol. 66 (6).– P. 545–552. https://doi.org/ 10.1177/0003319714542997.

Azab B., Zaher M., Weiserbs K.F. et al. Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction // Am. J. Cardiol.– 2010.– Vol. 106 (4).– P. 470–476. https://doi.org/10.1016/j.amjcard.2010.03.062.

Baginda Yusuf Siregar, Refli Hasan, Rahmad Isnanta. Association of Platelet Lymphocyte Ratio (PLR) and Neutro­­­phil Lymphocyte Ratio (NLR) with Global Registry of Acute Coronary Events (GRACE) Score in Acute Coronary Syndrome // Intern. J. Research and Review.– 2021.– Vol. 8 (5). https://doi.org/10.52403/ijrr.20210501.

Budzianowski J., Pieszko K., Burchardt P. et al. The Role of Hematological Indices in Patients with Acute Coronary Syndrome // Disease Markers.– 2017. https://doi.org/10.1155/2017/3041565.

Causes of Death. GBD Compare. 2019. https://vizhub.healthdata.org/gbd-compare/#settings=c22f4161680a3bc28a811e8acc7e8dd2a5e05e45

Cesari F., Marcucci R., Gori A.M. et al. Reticulated platelets predict cardiovascular death in acute coronary syndrome patients // Thromb. Haemostasis.– 2013.– Vol. 109 (5).– P. 846–853. https://doi.org/10.1160/TH12-09-0709.

Chia S., Nagurney J.T., Brown D.F. et al. Association of leukocyte and neutrophil counts with infarct size, left ventricular function and outcomes after percutaneous coronary intervention for ST-elevation myocardial infarction // Am. J. Cardiol.– 2009.– Vol. 103 (3).– P. 333–337. https://doi.org/10.1016/j.amjcard.2008.09.085.

Choi D.H., Kobayashi Y., Nishi T. et al. Combination of mean platelet volume and neutrophil to lymphocyte ratio predicts long-term major adverse cardiovascular events after percutaneous coronary intervention // Angiology.– 2019.– Vol. 70 (4).– P. 345–351. https://doi.org/10.1177/0003319718768658.

Dentali F., Nigro O., Squizzato A. et al. Impact of neutrophils to lymphocytes ratio on major clinical outcomes in patients with acute coronary syndromes: A systematic review and meta-analysis of the literature // Intern. J. Cardiology.– 2018.– Vol. 266.– Р. 31–37. https://doi.org/10.1016/j.ijcard.2018.02.116.

Desai K.N., Patel K., Shah M. et al. A study of platelet volume indices (PVI) in patients of coronary artery disease and acute myocardial infarction intertiary care hospital // Int. J. Adv. Res.– 2013.– Vol. 1 (6).– P. 185–191.

Frantz S., Hofmann U., Fraccarollo D. Monocytes/macrophages prevent healing defects and left ventricular thrombus formation after myocardial infarction // F.A.S.E.B. J.– 2013.– Vol. 3.– P. 871–881. https://doi.org/10.1096/fj.12-214049.

Frostegеrd J. The immune system in atherosclerosis. Immunomodulatory or antiinflammatory treatment that is effective against atherosclerosis and its complications are needed to ensure the hypothesis // Lakartidningen.– 2013.– Vol. 110 (43–44).– P. 1931–1934.

Gawlita M., Wasilewski J., Osadnik T. et al. Mean platelet volume and platelet-large cell ratio as prognostic factors for coronary artery disease and myocardial infarction // Folia Cardiologica.– 2015.– Vol. 10 (6).– P. 418–422. https://doi.org/10.5603/FC.2015.0079.

Hong D., Choi K.H., Song Y.B. et al. Prognostic implications of post-percutaneous coronary intervention neutrophil-to-lymphocyte ratio on infarct size and clinical outcomes in patients with acute myocardial infarction // Sci Rep.– 2019.– Vol. 9 (1).– 9646. Published 2019 Jul 4. https://doi.org/10.1038/s41598-019-46117-8.

Ibanez B., James S., Agewall S. et al. ESC Scientific Document Group, 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC) // Eur. Heart J.– 2018.– Vol. 39 (2).– P. 119–177. https://doi.org/10.1093/eurheartj/ehx393.

Idzkowska E., Eljaszewicz A., Miklasz P. et al. The role of different monocyte subsets in the pathogenesis of atherosclerosis and acute coronary syndromes // Scand. J. Immunol.– 2015.– Vol. 82 (3).– P. 163–173.https://doi.org/10.1111/sji.12314.

Kaptoge S., Angelantonio E.D. Emerging risk factors collaboration C-reactive protein, fibrinogen, and cardiovascular disease prediction // New Engl. J. Medicine.– 2012.– Vol. 367 (14).– P. 1310–1320. https://doi.org/10.1056/NEJMc1213688.

Kossmann H., Rischplerb Ch., Hanus F. et al. Monocyte-platelet aggregates affect local inflammation in patients with acute myocardial infarction // Int. J. Cardiol.– 2019.– Vol. 287.– P. 7–12. https://doi.org/10.1016/j.ijcard.2019.04.009.

Liu J., Ao W., Zhou J., Luo P. et al. The correlation between PLR-NLR and prognosis in acute myocardial infarction // Amer. J. Transl. Res.– 2021.– Vol. 13 (5).– P. 4892–4899.

Malhotra R., Marcelli D., von Gersdorff G. et al. Relationship of neutrophil-to-lymphocyte ratio and serum albumin levels with C-reactive protein in hemodialysis patients: results from 2 International Cohort Studies // Nephron.– 2015.– Vol. 130 (4).– P. 263–270. https://doi.org/10.1159/000437005.

McEvoy M., Attia J., Thakkinstian A. Neutrophil lymphocyte ratio and cardiovascular disease risk: a systematic review and meta-analysis // Published online.– 2018.– 11. https://doi.org/10.1155/2018/2703518.

Nikolsky E., Grines C.L., Cox D.A. et al. Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial) // Am. J. Cardiol.– 2007.– Vol. 99 (8).– P. 1055–1061. https://doi.org/10.1016/j.amjcard.2006.11.066.

Oylumlu M., Yıldız A., Oylumlu M. et al. Platelet-to-lymphocyte ratio is a predictor of in-hospital mortality patients with acute coronary syndrome // Anatol. J. Cardiol.– 2015.– Vol. 15 (4).– P. 277–283. https://doi.org/10.5152/akd.2014.5366.

Rechciński T., Jasińska A., Foryś J. et al. Prognostic value of platelet indices after acute myocardial infarction treated with primary percutaneous coronary intervention // Cardiol. J.– 2013.– Vol. 20.– P. 491–498. https://doi.org/10.5603/CJ.2013.0134.

Rieckmann M., Delgobo M., Gaal C. et al. Myocardial infarction triggers cardioprotective antigen-specific T helper cell responses // J. Clin. Investig.– 2019.– Vol. 130.– P. 4922–4936. https://doi.org/10.1172/JCI123859.

Shiyovich A., Gilutz H., Plakht Y. White blood cell subtypes are associated with a greater-long-term risk of death after acute myocardial infarction // Tex. Heart. Inst. J.– 2017.– Vol. 44 (3).– P. 176–188. https://doi.org/10.14503/THIJ-16-5768.

Shumilah A.M., Othman A.M., Al-Madhagi A.K. Accuracy of neutrophil to lymphocyte and monocyte to lymphocyte ratios as new inflammatory markers in acute coronary syndrome // BMC Cardiovasc. Disord.– 2021.– Vol. 422. https://doi.org/10.1186/s12872-021-02236-7.

Silvestre-Roig C., Braster Q., Ortega-Gomez A., Soehnlein O. Neutrophils as regulators of cardiovascular inflammation // Nature Reviews Cardiology.– 2020. https://doi.org/10.1038/s41569-019-0326-7.

Verdoia M., Nardin M., Gioscia R. et al. Atherosclerosis Study Group (NAS). Higher neutrophil-to-lymphocyte ratio (NLR) increases the risk of suboptimal platelet inhibition and major cardiovascular ischemic events among ACS patients receiving dual antiplatelet therapy with ticagrelor // Vascul. Pharmacol.– 2020.– Vol. 132.– P. 106765. https://doi.org/10.1016/j.vph.2020.106765.

Zouridakis E.G., Garcia-Moll X., Kaski J.C. Usefulness of the blood lymphocyte count in predicting recurrent instability and death in patients with unstable angina pectoris // Amer. J. Cardiology.– 2000.– Vol. 86 (4).– P. 449–451. https://doi.org/10.1016/s0002-9149(00)00963-2.

Most read articles by the same author(s)

1 2 3 4 > >>